Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > ETI therapy shows long-term health benefits—even when early lung function doesn’t improve

ETI therapy shows long-term health benefits—even when early lung function doesn’t improve

Resource Type

CF Research News

Authors

Mohamad Hadhud, Dan Halevy, Joel Reiter, Elad Ben Meir, Alex Gileles-Hillel, Ido Sadras, Eitan Kerem, Malena Cohen-Cymberknoh, Oded Breuer

References

J Cyst Fibros. 2025 Jun 2:S1569-1993(25)01486-9.  doi: 10.1016/j.jcf.2025.05.005.

Document

File JCF-D-25-00122R1_FINAL_Hadhud_220625.docx [1]

Keywords

Cystic fibrosis [2]
Drug response [3]
Elexacaftor/tezacaftor/ivacaftor [4]
Variation in treatment response [5]

Date

Thursday, June 5, 2025

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/eti-therapy-shows-long-term-health-benefits%E2%80%94even-when-early-lung

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00122R1_FINAL_Hadhud_220625.docx [2] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis [3] https://www.ecfs.eu/research-article-keywords/drug-response [4] https://www.ecfs.eu/research-article-keywords/elexacaftortezacaftorivacaftor [5] https://www.ecfs.eu/research-article-keywords/variation-treatment-response [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines